Mukesh Sehdev

Title: Mukesh Sehdev: Innovator in Antibody Production

Introduction

Mukesh Sehdev is a notable inventor based in Slough, GB. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant antibodies and proteins. With a total of 3 patents to his name, his work has the potential to impact therapeutic applications significantly.

Latest Patents

Mukesh's latest patents include a process for obtaining antibodies, which focuses on the manufacture of recombinant antibodies of therapeutic quality. This invention relates to methods for increasing the yield of functional antibodies from large-scale fermentations, where a cultured host cell sample undergoes a non-lysing treatment. Another significant patent involves methods for producing recombinant proteins. This invention provides a method for controlling the partitioning of a recombinant protein between the supernatant and the periplasm in E. coli host cell cultures. The method includes several steps, such as changing the growth rate of the E. coli host cells and inducing the expression of the recombinant protein.

Career Highlights

Mukesh Sehdev is currently associated with UCB Pharma, S.A., where he continues to innovate in the field of biotechnology. His work has been instrumental in advancing methods that enhance the efficiency of protein production, which is crucial for therapeutic developments.

Collaborations

Throughout his career, Mukesh has collaborated with notable colleagues, including David John Glover and Dominic Gambier Reeks. These collaborations have likely contributed to the success of his innovative projects.

Conclusion

Mukesh Sehdev's contributions to biotechnology, particularly in antibody and protein production, highlight his role as a significant inventor in the field. His patents reflect a commitment to advancing therapeutic solutions through innovative methods.